Using DNA and Antibody Microarrays for Functional Analysis
Author Information
Author(s): Andreas Bauer, Boris Beckmann, Christian Busold, Ole Brandt, Wlad Kusnezow, Janne Pullat, Verena Aign, Kurt Fellenberg, Robert Fleischer, Anette Jacob, Marcus Frohme, Jörg D. Hoheisel
Primary Institution: Deutsches Krebsforschungszentrum (DKFZ)
Conclusion
Microarray technology has significantly advanced and is now a vital tool for functional research, especially in cancer diagnostics and treatment.
Supporting Evidence
- Microarrays can analyze thousands of genes simultaneously.
- DNA microarrays are being developed for early diagnosis and treatment evaluation in cancer.
- Collaborative studies are being conducted to understand the genetic basis of lymphoid neoplasms.
Takeaway
Scientists are using special tools called microarrays to study genes and proteins, which helps them understand diseases like cancer better.
Methodology
The study involved the use of DNA and antibody microarrays to analyze gene expression and protein interactions in various biological samples.
Limitations
The study highlights that while microarray technology is promising, it still has limitations in terms of sample complexity and the need for further development.
Participant Demographics
The study involved 600 patients with lymphoid neoplasms and 600 matched unaffected individuals.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website